Articles

Original Article

The Role of ¹⁸F-FDG PET/CT in Evaluating the Efficacy of Radiofrequency Ablation in Metastatic and Primary Liver Tumors: Preliminary Results

Gabriela Mateva
Stoyan Handzhiev
Irena Kostadinova

Mol Imaging Radionucl Ther 2021; 30: 1-7 DOI: 10.4274/mirt.galenos.2020.63634 PMID:33586401

Comparison of Radioactive Iodine Activities in Terms of Short- and Long-term Results in Ablation Therapy in Patients with Low-risk Differentiated Thyroid Cancer

Seray Saraçoğlu
Osman Güven
Gündüzalp Buğrahan Babacan
Savaş Karyağar
Tamer Özülker
Sadık Ergür
Sevda Sağlampınar Karyağar

Mol Imaging Radionucl Ther 2023; 32: 112-116 DOI: 10.4274/mirt.galenos.2022.05826 PMID:37337764

Review

Radioactive Iodine Remnant Ablation: The Beta-knife Completion Thyroidectomy

Seza Gulec
Russ Kuker

Mol Imaging Radionucl Ther 2017; 26: 16-23 DOI: 10.4274/2017.26.suppl.03 PMID:28117286

Original Research

Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success?

Zekiye Hasbek
Bülent Turgut

Mol Imaging Radionucl Ther 2016; 25: 79-84 DOI: 10.4274/mirt.88598 PMID:27277324

The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment

Tülay Kaçar Güveli
Sezer Özkan
Müge Öner Tamam
Ercan Uyanık
Nurcan Ediz
Mehmet Mülazımoğlu
Tevfik Özpaçacı

Mol Imaging Radionucl Ther 2014; 23: 84-88 DOI: 10.4274/mirt.33042 PMID:25541931

Original Articles

The Effects of the Factors Related to the Patient and the Disease on the Performance of Ablation Therapy in Patients with Differentiated Thyroid Cancer who have Received I-131 Ablation Therapy

Tarik Sengöz
Erdem Sürücü
Yusuf Demir
Erkan Derebek

Mol Imaging Radionucl Ther 2012; 21: 103-109 DOI: 10.4274/Mirt.25744 PMID:23487510

About Journal

Forms

Useful Links

Latest Update: 16.04.2024